Statin loading before coronary artery bypass grafting: a randomized trial

Area of Science:

• Cardiology
• Cardiovascular Surgery
• Pharmacology

Background:

• Long-term statin therapy is standard for cardiovascular disease.
• High-dose statin loading before percutaneous coronary revascularization may improve outcomes.
• The benefit of additional statin loading before surgical revascularization is unclear.

Purpose of the Study:

• To evaluate the efficacy of high-dose statin loading prior to coronary artery bypass grafting (CABG).
• To determine if additional statin therapy reduces major adverse cardiac and cerebrovascular events (MACCE) post-CABG.

Main Methods:

• A randomized, double-blind, placebo-controlled trial involving 2635 adult patients on long-term statins scheduled for isolated CABG.
• Patients received either high-dose statin loading or placebo 12 and 2 hours before surgery.
• The primary outcome was a composite of all-cause mortality, myocardial infarction, and cerebrovascular events within 30 days.

Main Results:

• No statistically significant difference in MACCE was observed between the statin group (13.9%) and the placebo group (14.9%).
• Secondary endpoints, including cardiac death, myocardial infarction, myocardial injury, and 12-month mortality, were comparable between groups.
• The study included 2406 patients in the modified intention-to-treat analysis.

Conclusions:

• Additional high-dose statin loading before CABG did not reduce the rate of MACCE within 30 days.
• The findings indicate no benefit from this perioperative statin strategy in patients already on long-term statin therapy.
• Further research may explore alternative perioperative strategies for cardiac surgery patients.